Caron A Jacobson Selected Research

Caron A Jacobson Research Topics

Disease

31	B-Cell Lymphoma (Lymphoma, B Cell) 04/2024 - 12/2017
18	Lymphoma (Lymphomas) 02/2024 - 01/2017
14	Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular) 04/2024 - 09/2012
14	Neoplasms (Cancer) 11/2023 - 01/2017
12	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 02/2024 - 12/2017
10	Non-Hodgkin Lymphoma (Lymphosarcoma) 10/2023 - 01/2019
8	Mantle-Cell Lymphoma (Lymphoma, Mantle Cell) 12/2023 - 01/2019
7	Disease Progression 02/2024 - 01/2019
7	Cytokine Release Syndrome 01/2024 - 01/2019
6	Residual Neoplasm 01/2024 - 08/2019
5	Leukemia 12/2023 - 11/2016
4	B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia) 01/2024 - 01/2016
4	Hematologic Neoplasms (Hematological Malignancy) 12/2023 - 01/2019
4	Hodgkin Disease (Hodgkin's Disease) 12/2022 - 01/2012
3	cell-associated neurotoxicity 10/2023 - 11/2022
3	Infections 01/2019 - 04/2012
3	Bronchiolitis Obliterans Syndrome 05/2014 - 11/2010
2	Multiple Myeloma 01/2023 - 11/2022
2	Lymphoproliferative Disorders (Lymphoproliferative Disorder) 01/2023 - 09/2010
2	Body Weight (Weight, Body) 01/2020 - 12/2017
1	Hepatic Veno-Occlusive Disease (Disease, Hepatic Veno-Occlusive) 11/2023
1	Neurotoxicity Syndromes (Toxic Encephalopathy) 11/2023
1	Agammaglobulinemia (Hypogammaglobulinemia) 01/2023
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2023
1	Heart Failure 01/2023
1	Neutropenia 11/2022
1	Cytopenia 11/2022
1	Mycoses (Diseases, Fungus) 01/2022
1	Tumor Lysis Syndrome 01/2022
1	Spinal Cord Diseases 12/2021
1	Pathologic Complete Response 10/2021
1	Carcinogenesis 01/2021
1	Carcinoma (Carcinomatosis) 01/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 11/2020
1	Inflammation (Inflammations) 10/2020
1	Hypokalemia 01/2020
1	Hyponatremia 01/2020
1	Acute Kidney Injury (Acute Renal Failure) 01/2020
1	Cardiac Sudden Death (Sudden Cardiac Arrest) 08/2019
1	Adrenal Insufficiency (Adrenal Gland Hypofunction) 01/2019
1	Hypoxia (Hypoxemia) 01/2019
1	Atrial Fibrillation 01/2019

Drug/Important Bio-Agent (IBA)

39	Chimeric Antigen ReceptorsIBA 04/2024 - 12/2017
29	axicabtagene ciloleucelIBA 04/2024 - 12/2017
4	tocilizumab (atlizumab)FDA Link 01/2024 - 01/2019
4	ibrutinibIBA 01/2024 - 01/2019
4	Rituximab (Mabthera)FDA Link 01/2024 - 01/2016
4	Biomarkers (Surrogate Marker)IBA 12/2023 - 11/2016
3	AnthracyclinesIBA 02/2024 - 01/2019
3	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2024 - 01/2019
3	fludarabineIBA 01/2024 - 12/2017
3	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2024 - 12/2017
3	tisagenlecleucelIBA 10/2023 - 12/2019
3	Bendamustine Hydrochloride FDA Link 10/2023 - 01/2016
3	pembrolizumabIBA 01/2023 - 01/2019
3	venetoclaxIBA 01/2022 - 12/2019
3	idelalisibIBA 12/2019 - 01/2016
2	Atorvastatin (Lipitor)FDA Link 02/2024 - 01/2023
2	Immunoglobulins (Immunoglobulin)IBA 12/2023 - 12/2022
2	brexucabtagene autoleucelIBA 01/2023 - 01/2020
2	bis(3- bis(4- chlorophenyl)methyl- 4- dimethylaminophenyl)amineIBA 01/2023 - 11/2022
2	Monoclonal AntibodiesIBA 01/2022 - 01/2019
2	Agammaglobulinaemia Tyrosine KinaseIBA 01/2020 - 01/2019
2	Lenalidomide (CC 5013)FDA Link 12/2019 - 01/2016
1	defibrotideIBA 11/2023
1	AntibodiesIBA 10/2023
1	utomilumabIBA 10/2023
1	serum P-component (CIt)IBA 02/2023
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 11/2022
1	PNT100IBA 01/2022
1	Alkylating AgentsIBA 01/2022
1	DNA (Deoxyribonucleic Acid)IBA 01/2022
1	OligonucleotidesIBA 01/2022
1	A-Form DNA (A-DNA)IBA 01/2022
1	siltuximabIBA 12/2021
1	acalabrutinibIBA 10/2021
1	obinutuzumabIBA 10/2021
1	Nuclear Proteins (Protein, Nuclear)IBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	Antigen Receptors (Antigen Receptor)IBA 01/2021
1	polatuzumab vedotinIBA 01/2021
1	RO6870810IBA 01/2021
1	Tolnaftate (Ting)IBA 11/2020
1	ElectrolytesIBA 01/2020
1	tazemetostatIBA 12/2019
1	Immunomodulating AgentsIBA 12/2019
1	Enhancer of Zeste Homolog 2 ProteinIBA 12/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2019
1	Phosphatidylinositol 3-Kinases (PI 3 Kinase)IBA 01/2019
1	Lipase (Acid Lipase)FDA Link 01/2019

Therapy/Procedure

47	Therapeutics 03/2024 - 11/2010
15	Drug Therapy (Chemotherapy) 02/2024 - 01/2017
14	Stem Cell Transplantation 12/2023 - 01/2017
7	Immunotherapy 11/2023 - 01/2018
3	Transplantation 12/2019 - 04/2012
2	Blood Component Removal (Apheresis) 12/2023 - 12/2022
2	Cell Transplantation 11/2023 - 12/2019
2	Radiotherapy 11/2023 - 09/2012
2	Organ Transplantation 01/2023 - 09/2010
1	Aftercare (After-Treatment) 01/2020